Summary

Disapproves and nullifies a Centers for Medicare & Medicaid Services rule for Medicare Calendar Year 2025 that would have updated home health payment rates and related policies. The rule changes covered the Home Health Prospective Payment System rates, home health quality reporting, expansion of a home health value‑based purchasing model, and a rate update for home intravenous immune globulin (IVIG) items and services; this legislation declares that rule to have no force or effect.

• Nullifies a CMS Medicare rule for Calendar Year 2025 that targeted home health payments and policies.
• Stops the CY2025 Home Health Prospective Payment System rate update from taking effect.
• Prevents implementation of home health quality reporting changes and an expanded value‑based purchasing model.
• Blocks the CY2025 rate update for home IVIG items and services provided in the home setting.
• Does not change statute or appropriate additional funds—it disapproves an administrative rule.
• Maintains the existing regulatory status quo for the affected home‑health provisions until CMS acts again.
• Primary impacts are on home‑health providers, home infusion suppliers, and Medicare beneficiaries receiving home care.